P2RY12 and atherosclerosis: Previous studieshave shown that P2Y12 inhibitors could at least provide similar protectiveeffects in patients with established atherosclerosis, compared to aspirin [5].The pharmacodynamics of P2Y12 inhibitors endows them with more profoundplatelet inhibition than aspirin [20].